EX-308 EXCIMER LASER FOR PHOTOTHERAPY TREATMENT OF VITILIGO
K-Number: K020973 · 2002-03-29
Advertisement
Device Summary
Frequently Asked Questions
What is the EX-308 EXCIMER LASER FOR PHOTOTHERAPY TREATMENT OF VITILIGO?
EX-308 EXCIMER LASER FOR PHOTOTHERAPY TREATMENT OF VITILIGO is a medical device that received FDA 510(k) clearance on 2002-03-29. The listed applicant is Surgilight, Inc.. The 510(k) number is K020973.
When did EX-308 EXCIMER LASER FOR PHOTOTHERAPY TREATMENT OF VITILIGO receive FDA 510(k) clearance?
EX-308 EXCIMER LASER FOR PHOTOTHERAPY TREATMENT OF VITILIGO received FDA 510(k) clearance on 2002-03-29, under 510(k) number K020973.
Who is the listed applicant for EX-308 EXCIMER LASER FOR PHOTOTHERAPY TREATMENT OF VITILIGO?
The FDA 510(k) record lists Surgilight, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for EX-308 EXCIMER LASER FOR PHOTOTHERAPY TREATMENT OF VITILIGO?
The FDA product code for EX-308 EXCIMER LASER FOR PHOTOTHERAPY TREATMENT OF VITILIGO is GEX. This falls under the Gastroenterology category.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Surgilight, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: GEX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement